Deficiency of interleukin-17 receptor A1 induces microbiota disruption in the intestine of Japanese medaka, Oryzias latipes.
16S rRNA-based metagenomic analysis
Interleukin 17 receptor A
Intestinal immune system
Japanese medaka (Oryzias latipes)
Plesiomonas shigelloides
Journal
Comparative biochemistry and physiology. Part D, Genomics & proteomics
ISSN: 1878-0407
Titre abrégé: Comp Biochem Physiol Part D Genomics Proteomics
Pays: Netherlands
ID NLM: 101270611
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
28
08
2020
revised:
11
06
2021
accepted:
17
07
2021
pubmed:
3
8
2021
medline:
15
12
2021
entrez:
2
8
2021
Statut:
ppublish
Résumé
The mutual relationship between the intestinal immune system and the gut microbiota has received a great deal of attention. In mammals, interleukin-17A and F (IL-17A/F) are inflammatory cytokines and key regulators of the gut microbiota. However, in teleosts, the function of IL-17A/F in controlling the gut microbiota is poorly understood. We attempted to elucidate the importance of teleost IL-17 signaling in controlling gut microbiota. We previously established a knockout (KO) of IL-17 receptor A (RA) 1, a receptor for IL-17A/F, in the Japanese medaka (Oryzias latipes) using the CRISPR-Cas9 system and performed 16S rRNA-based metagenomic analyses using the anterior and posterior sections of the intestinal tract. The number of observed OTUs in the anterior intestine was significantly decreased in IL-17RA1 KO medaka compared to that in the wild-type (WT). Furthermore, β-diversity analysis (weighted UniFrac) revealed considerably different bacterial composition in the anterior intestine of IL-17RA1 KO compared to WT, with similar findings in α-diversity. Notably, the pathogen Plesiomonas shigelloides was significantly increased in the posterior intestine of IL-17RA1 KO medaka. These findings indicate that signaling via IL-17RA1 is required to maintain a healthy gut microbiota in teleosts and mammals. The involvement of IL-17RA1 in controlling the gut microbiota has been demonstrated, resulting in microbiome dysbiosis in IL-17RA1 KO medaka.
Identifiants
pubmed: 34339936
pii: S1744-117X(21)00097-6
doi: 10.1016/j.cbd.2021.100885
pii:
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Receptors, Interleukin-17
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
100885Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.